Synthetic Antibacterial Quaternary Phosphorus Salts Promote Methicillin-Resistant Staphylococcus aureus -Infected Wound Healing

Drug-resistant microbes pose a global health concern, requiring the urgent development of effective antibacterial agents and strategies in clinical practice. Therefore, there is an urgent need to explore novel antibacterial materials to effectively eliminate bacteria. The synthesis of quaternary pho...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of nanomedicine Vol. 18; pp. 1145 - 1158
Main Authors Shi, Liang-Wen, Zhuang, Quan-Quan, Wang, Tai-Qin, Jiang, Xian-Dong, Liu, Yue, Deng, Jing-Wen, Sun, Huan-Huan, Li, Yi, Li, Hao-Hong, Liu, Ting-Bo, Liu, Jian-Zhi
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 01.01.2023
Taylor & Francis Ltd
Dove
Dove Medical Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Drug-resistant microbes pose a global health concern, requiring the urgent development of effective antibacterial agents and strategies in clinical practice. Therefore, there is an urgent need to explore novel antibacterial materials to effectively eliminate bacteria. The synthesis of quaternary phosphonium salt in haloargentate systems, wherein the phosphorus atom is represented in a cationic form, is a possible strategy for the development of antibacterial materials. Using (triphenyl)phosphonium-based quaternary phosphorus salts with different spacer lengths (n=2, 4, 6) as a template, we designed three kinds of quaternary phosphorus salts as effective antibacterial agents against drug-resistant bacteria. The synthesized quaternary phosphorus salt of (1,4-DBTPP)Br effectively prevented the formation of the bacterial biofilms, and degraded bacterial membranes and cell walls by promoting the production of reactive oxygen species, which exhibited effective therapeutic effects in a rat model of a superficial wound infected with methicillin-resistant . The quaternary phosphorus salt (1,4-DBTPP)Br demonstrated hemocompatibility and low toxicity, revealing its potential in the treatment of clinical infections.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work
ISSN:1178-2013
1176-9114
1178-2013
DOI:10.2147/IJN.S398748